These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9212016)

  • 1. Pelvic exenteration for cervix cancer: would additional intraoperative interstitial brachytherapy improve survival?
    Beitler JJ; Anderson PS; Wadler S; Runowicz CD; Hayes MK; Fields AL; Sood B; Goldberg GL
    Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):143-8. PubMed ID: 9212016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?
    Backes FJ; Billingsley CC; Martin DD; Tierney BJ; Eisenhauer EL; Cohn DE; O'Malley DM; Salani R; Copeland LJ; Fowler JM
    Gynecol Oncol; 2014 Oct; 135(1):95-9. PubMed ID: 25084510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
    Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
    Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review].
    Sardain H; Lavoué V; Foucher F; Levêque J
    J Gynecol Obstet Biol Reprod (Paris); 2016 Apr; 45(4):315-29. PubMed ID: 26874666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.
    Tanaka S; Nagase S; Kaiho-Sakuma M; Nagai T; Kurosawa H; Toyoshima M; Tokunaga H; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
    Int J Clin Oncol; 2014 Feb; 19(1):133-8. PubMed ID: 23404487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of locally advanced and recurrent cervical carcinoma: overview on current standard and new developments.
    Höckel M
    Onkologie; 2003 Oct; 26(5):452-5. PubMed ID: 14605461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of loco-regional recurrences of cervix cancers].
    Bobin JY; Romestaing P; Gérard JP
    Ann Chir; 1999; 53(9):904. PubMed ID: 10633941
    [No Abstract]   [Full Text] [Related]  

  • 9. Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery.
    Caceres A; Mourton SM; Bochner BH; Gerst SR; Liu L; Alektiar KM; Kardos SV; Barakat RR; Boland PJ; Chi DS
    Int J Gynecol Cancer; 2008; 18(5):1139-44. PubMed ID: 18053063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
    Deng H; Wang JL; Wang ZQ; Li XW; Hu H; Yang B; Zhang XM; Shen K; Guo P; Liang B
    Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):259-265. PubMed ID: 32375433
    [No Abstract]   [Full Text] [Related]  

  • 11. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.
    Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF
    Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix.
    Shingleton HM; Soong SJ; Gelder MS; Hatch KD; Baker VV; Austin JM
    Obstet Gynecol; 1989 Jun; 73(6):1027-34. PubMed ID: 2726106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic exenteration for adenocarcinoma of the uterine cervix.
    Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT
    Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open interstitial brachytherapy for the treatment of local-regional recurrences of uterine corpus and cervix cancer after primary surgery.
    Monk BJ; Walker JL; Tewari K; Ramsinghani NS; Nisar Syed AM; DiSaia PJ
    Gynecol Oncol; 1994 Feb; 52(2):222-8. PubMed ID: 8314143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pelvic exenteration for recurrent or persistent cervical cancer: experience of five years at the National Cancer Institute in Mexico.
    Terán-Porcayo MA; Zeichner-Gancz I; del-Castillo RA; Beltrán-Ortega A; Solorza-Luna G
    Med Oncol; 2006; 23(2):219-23. PubMed ID: 16720922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: single institution experience.
    Landoni F; Zanagnolo V; Rosenberg PG; Lopes A; Radice D; Bocciolone L; Aletti G; Parma G; Colombo N; Maggioni A
    Gynecol Oncol; 2013 Jul; 130(1):69-74. PubMed ID: 23474343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
    Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
    Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage High-dose-rate Interstitial Brachytherapy for Pelvic Recurrent Cervical Carcinoma After Hysterectomy.
    Murakami N; Kato T; Miyamoto Y; Nakamura S; Wakita A; Okamoto H; Tsuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Takahashi K; Umezawa R; Inaba K; Ito Y; Igaki H; Itami J
    Anticancer Res; 2016 May; 36(5):2413-21. PubMed ID: 27127151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status and outcomes of pelvic exenteration for recurrent cervical cancer: a systematic review].
    Chen M; Pan L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):460-5. PubMed ID: 25169641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pelvic wall recurrence of cervix carcinomas. Combined surgical-radio-chemotherapeutic procedure (CORCT)].
    Schulz-Wendtland R; Krämer S; Säbel M; Heller F; Keilholz L; Jäger W; Sauer R; Lang N; Bautz W
    Strahlenther Onkol; 1998 May; 174(5):279-83. PubMed ID: 9614958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.